Literature DB >> 24652021

Liver hepatotoxicity associated with pantoprazole: a rare case report.

Mehmet Aslan1, Yilmaz Celik, Sevdegul Karadas, Sehmus Olmez, Adem Cifci.   

Abstract

Hepatotoxicity may occasionally develop over the course of treatment with proton pump inhibitors (PPIs). Although skin reactions, interstitial nephritis, pancytopenia, anaphylaxis, and generalized edema have been reported to be associated with PPIs, hepatotoxicity associated with oral pantoprazole is very rare. In this report, we present a case of hepatotoxicity in a 35-year-old man who received pantoprazole (40 mg/day) for acute gastritis. One week after discontinuation of pantoprazole, his liver function began to improve, and the patient gradually fully recovered. Although this toxicity occurs only infrequently, pantoprazole should be considered as a rare hepatotoxic agent in the literature.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24652021     DOI: 10.1007/s00508-014-0535-3

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  20 in total

1.  Multiple organ failure related to pantoprazole.

Authors:  I F Yusoff; P Nairn; C A Morgan
Journal:  Aust N Z J Med       Date:  1999-12

2.  Proton-pump-inhibitor-induced hepatitis.

Authors:  Kamran Darabi
Journal:  South Med J       Date:  2005-08       Impact factor: 0.954

3.  Anaphylaxis to pantoprazole during general anesthesia.

Authors:  Hou-Chuan Lai; Shih-Wei Hsu; Chueng-He Lu; Hsin-I Ma; Chen-Hwan Cherng; Nan-Kai Hung; Ching-Tang Wu
Journal:  J Anesth       Date:  2011-05-29       Impact factor: 2.078

4.  Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction.

Authors:  G M Ferron; R A Preston; R J Noveck; P Pockros; P Mayer; J Getsy; M Turner; M Abell; J Paul
Journal:  Clin Ther       Date:  2001-08       Impact factor: 3.393

5.  Pharmacokinetics and tolerance of pantoprazole, a proton pump inhibitor after single and multiple oral doses in healthy Japanese volunteers.

Authors:  M Tanaka; H Yamazaki; Y Ryokawa; H Hakusui; N Nakamichi; H Sekino
Journal:  Int J Clin Pharmacol Ther       Date:  1996-10       Impact factor: 1.366

6.  Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole.

Authors:  Aurore Gouraud; Véronique Vochelle; Jacques Descotes; Thierry Vial
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

7.  Pantoprazole induces severe acute hepatitis.

Authors:  C Sandig; C Flechtenmacher; W Stremmel; C Eisenbach
Journal:  Z Gastroenterol       Date:  2011-02-04       Impact factor: 2.000

8.  Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.

Authors:  J P Gisbert; L González; X Calvet; M Roqué; R Gabriel; J M Pajares
Journal:  Aliment Pharmacol Ther       Date:  2001-07       Impact factor: 8.171

Review 9.  Interaction of proton pump inhibitors with cytochromes P450: consequences for drug interactions.

Authors:  U A Meyer
Journal:  Yale J Biol Med       Date:  1996 May-Jun

10.  Pharmacokinetics and pharmacodynamics of the proton pump inhibitors.

Authors:  Jai Moo Shin; Nayoung Kim
Journal:  J Neurogastroenterol Motil       Date:  2013-01-08       Impact factor: 4.924

View more
  2 in total

1.  Pantoprazole-induced acute kidney injury: A case report.

Authors:  Tao Peng; Zhao Hu; Hongnan Zheng; Junhui Zhen; Chengjun Ma; Xiangdong Yang
Journal:  Exp Ther Med       Date:  2018-04-23       Impact factor: 2.447

2.  Pharmacokinetics and Tissue Levels of Pantoprazole in Neonatal Calves After Intravenous Administration.

Authors:  Jeff D Olivarez; Amanda J Kreuder; Dane M Tatarniuk; Larry W Wulf; Katarzyna A Dembek; Jonathan P Mochel; Joe S Smith
Journal:  Front Vet Sci       Date:  2020-11-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.